Early detection of Alzheimer's disease (AD) pathologies, specifically β-amyloid and hyperphosphorylated tau, facilitates identification of individuals at risk of Alzheimer's disease and related dementias (ADRD). This evidence concerns the gene MAPT and Alzheimer disease.